Quantcast

Latest treatment of migraine Stories

2015-02-09 08:31:40

CAMBIA® (Diclofenac Potassium for Oral Solution) is elevated to Level A, based on rigorous clinical data demonstrating its effectiveness for acute migraine attacks, consistent with other therapies

2015-01-13 08:29:51

DURHAM, N.C., Jan. 13, 2015 /PRNewswire/ -- CoLucid Pharmaceuticals, Inc., today announced that it has completed a $37.1 million Series C preferred stock offering.

2014-03-27 08:34:36

AVP-825 relies on novel closed palate Breath Powered(TM) drug delivery technology YARDLEY, Pa., March 27, 2014 /PRNewswire/ -- The U.S.

2014-03-26 08:30:13

ALISO VIEJO, Calif., March 26, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S.

2014-01-30 08:32:03

ALISO VIEJO, Calif., Jan. 30, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it has submitted a New Drug Application (NDA) to the U.S.

2014-01-22 12:26:19

New Guidelines Support Use by Migraine Specialists in the UK SUNNYVALE, Calif., Jan.


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.